Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
25
27
28
29
1
3
5
6
7
8
11
13
15
17
18
19
20
21
22
24
25
27
28
29
31
1
2
3
4
5
3rd International conference on  Diabetes, Hypertension and Metabolic Syndrome
2020-02-24 - 2020-02-25    
All Day
About Diabetes Meet 2020 Conference Series takes the immense Pleasure to invite participants from all over the world to attend the 3rdInternational conference on Diabetes, Hypertension and [...]
3rd International Conference on Cardiology and Heart Diseases
2020-02-24 - 2020-02-25    
All Day
ABOUT 3RD INTERNATIONAL CONFERENCE ON CARDIOLOGY AND HEART DISEASES The standard goal of Cardiology 2020 is to move the cardiology results and improvements and to [...]
Medical Device Development Expo OSAKA
2020-02-26 - 2020-02-28    
All Day
ABOUT MEDICAL DEVICE DEVELOPMENT EXPO OSAKA What is Medical Device Development Expo OSAKA (MEDIX OSAKA)? Gathers All Kinds of Technologies for Medical Device Development! This [...]
Beauty Care Asia Pacific Summit 2020 (BCAP)
2020-03-02 - 2020-03-04    
All Day
Groundbreaking Event to Address Asia-Pacific’s Growing Beauty Sector—Your Window to the World’s Fastest Growing Beauty Market The international cosmetics industry has experienced a rapid rise [...]
IASTEM - 789th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-03-04 - 2020-03-05    
All Day
IASTEM - 789th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 4th - 5th March, 2020 at Hamburg, Germany . [...]
Global Drug Delivery And Formulation Summit 2020
2020-03-09 - 2020-03-11    
All Day
Innovative solutions to the greatest challenges in pharmaceutical development. Price: Full price delegate ticket: GBP 1495.0. Time: 9:00 am to 6:00 pm About Conference KC [...]
Inborn Errors Of Metabolism Drug Development Summit 2020
2020-03-10 - 2020-03-12    
All Day
Confidently Translate, Develop and Commercialize Gene, mRNA, Replacement Therapies, Small Molecule and Substrate Reduction Therapies to More Efficaciously Treat Inherited Metabolic Diseases. Time: 8:00 am [...]
Texting And E-Mail With Patients: Patient Requests And Complying With HIPAA
2020-03-12    
All Day
Overview:  This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what [...]
14 Mar
2020-03-14 - 2020-03-21    
All Day
Topics in Family Medicine, Hematology, and Oncology CME Cruise. Prices: USD 495.0 to USD 895.0. Speakers: David Parrish, MS, MD, FAAFP, Alexander E. Denes, MD, [...]
International Conference On Healthcare And Clinical Gerontology ICHCG
2020-03-14 - 2020-03-15    
All Day
An elegant and rich premier global platform for the International Conference on Healthcare and Clinical Gerontology ICHCG that uniquely describes the Academic research and development [...]
World Congress And Expo On Cell And Stem Cell Research
2020-03-16 - 2020-03-17    
All Day
"The world best platform for all the researchers to showcase their research work through OralPoster presentations in front of the international audience, provided with additional [...]
25th International Conference on  Diabetes, Endocrinology and Healthcare
2020-03-23 - 2020-03-24    
All Day
About Conference: Conference Series LLC Ltd is overwhelmed to announce the commencement of “25th International Conference on Diabetes, Endocrinology and Healthcare” to be held during [...]
ISN World Congress of Nephrology 2020
2020-03-26 - 2020-03-29    
All Day
ABOUT ISN WORLD CONGRESS OF NEPHROLOGY 2020 ISN World Congress of Nephrology (WCN) takes place annually to enable this premier educational event more available to [...]
30 Mar
2020-03-30 - 2020-03-31    
All Day
This Cardio Diabetes 2020 includes Speaker talks, Keynote & Poster presentations, Exhibition, Symposia, and Workshops. This International Conference will help in interacting and meeting with diabetes and [...]
Trending Topics In Internal Medicine 2020
2020-04-02 - 2020-04-04    
All Day
Trending Topics in Internal Medicine is a CME course that will tackle the latest information trending in healthcare today.   This course will help you discuss options [...]
2020 Summit On National & Global Cancer Health Disparities
2020-04-03 - 2020-04-04    
All Day
The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer [...]
Events on 2020-02-26
Events on 2020-03-02
Events on 2020-03-09
Events on 2020-03-10
Events on 2020-03-16
Events on 2020-03-26
Events on 2020-03-30
Events on 2020-04-02
Events on 2020-04-03
Articles

Nov 09: Diversicare Healthcare Services Management Announces Q3 Results

diversicare healthcare services management

Good morning, and welcome to the Diversicare Healthcare Services Management Third Quarter Conference Call. Today’s call is being recorded. I would like to remind everyone that in addition to historical information, certain comments made during this conference call will be forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. And these statements involve risks and uncertainties that may cause actual events, results and/or performances to differ materially from those indicated by such statements. You are encouraged to review the risk factors and forward-looking statement disclosures on the company — that the company has provided in its annual report on Form 10-K for the fiscal year ended December 31, 2012, as well as in its public filings with the Securities and Exchange Commission.

During today’s call, references may be made to non-GAAP financial measures. Investors are encouraged to review those non-GAAP financial measures and the reconciliation of those measures to the comparable GAAP results in our press release furnished under Form 8-K.

I would now like to turn the call over to Kelly Gill, the President and Chief Executive Officer.

Kelly J. Gill – Chief Executive Officer, President and Director

Good morning. Thank you, operator, and thanks to all of you for joining our call today.

Also with me is our Chief Financial Officer, Jay McKnight, who will provide some financial details later in the call.

This quarter marks the 1 year anniversary of having Jay and Leslie Campbell, our Chief Operating Officer, joining me as the leadership for the company. I’d like to start by acknowledging everything we have accomplished to-date.

As we discuss our results for the quarter, I want to put those results in the context of all the changes we’ve made in 1 year to adjust to challenges the company has faced historically. Most notably and in a relatively short period of time, we’ve taken bold steps to reduce our exposure to professional liability risk by divesting 12 facilities in a difficult state.

To accomplish this, we added 11 facilities or 1,391 beds. This is roughly the equivalent bed capacity of the Arkansas group, thereby repositioning our portfolio geographically with increased revenue and earnings per bed.

Not only did we accomplish this, but we also concurrently expanded our financial capacity with our banking group and established an additional relationship with Aviv REIT. And I want to thank them for their support and confidence in us.

Likewise, we’ve enjoyed a long-standing relationship with Omega Health Investors and the strength of our relationship continues to build. I also want to publicly thank Omega for their support in constructively assisting us in transitioning the Arkansas facilities to another capable provider in the state. We are extremely honored to enjoy a mutually rewarding relationship with our strategic partners, not only with Omega and Aviv, but also with our banking partners led by The PrivateBank in Chicago.

None of this could have been possible without Jay and Leslie’s leadership and all of the hard work of Diversicare’s 6,000 employees in all the states in which we operate, and I want to recognize them as well today.

As I discuss our third quarter, I also want to point out that all of these changes have yet to be reflected in our reported results, and moreover, that some continue to be works in progress. So I want to first give a status update on the strategic steps we’ve taken and how they impacted the quarter.

To begin, we completed the disposition of our remaining Arkansas facilities at the beginning of September, and the operating results of those facilities are classified as discontinued operations for both the 2013 and 2012 third quarters.  source